Evidence map›Paper›PMID 37304473›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2023

The Circular RNA Circ-ANAPC7 as a Biomarker for the Risk Stratification of Myelodysplastic Syndrome.

Fang Zhou, Shuying Zhang, Mei Huo, Ying Zhou, Libo Jiang, Hong Zhou, Ying Qu

Open access · hybridAbstract read
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fang ZhouDepartment of Laboratory Diagnosis, The Second Affiliated Hospital of Qiqihar Medical College, No. 37, Zhong Huaxi Road, Qiqihar, Heilongjiang China.ORCID 0000-0002-2872-4321
Shuying ZhangDepartment of Laboratory Diagnosis, The Second Affiliated Hospital of Qiqihar Medical College, No. 37, Zhong Huaxi Road, Qiqihar, Heilongjiang China.
Mei HuoDepartment of Laboratory Diagnosis, The Second Affiliated Hospital of Qiqihar Medical College, No. 37, Zhong Huaxi Road, Qiqihar, Heilongjiang China.
Ying ZhouDepartment of Laboratory Diagnosis, The Second Affiliated Hospital of Qiqihar Medical College, No. 37, Zhong Huaxi Road, Qiqihar, Heilongjiang China.
Libo JiangDepartment of Hematology, The Second Affiliated Hospital of Qiqihar Medical College, Qiqihar, China.
Hong ZhouDepartment of Hematology, The Second Affiliated Hospital of Qiqihar Medical College, Qiqihar, China.
Ying QuDepartment of Laboratory Diagnosis, The Second Affiliated Hospital of Qiqihar Medical College, No. 37, Zhong Huaxi Road, Qiqihar, Heilongjiang China.
Qiqihar Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the diagnostic value of circ-ANAPC7 expression levels in MDS and its risk stratification. This is a retrospective observational study. This study enrolled 125 patients diagnosed with MDS and divided them into five groups according to IPSS-R (very high group, 25; high group, 25; intermediate group, 25; low group, 25; and very low group, 25), and 25 patients with IDA were studied as control group from our bone marrow cell bank. Bone marrow cell were used as material in this study to measure the expression level of circ-ANAPC7 by qRT-PCR. An evaluation of diagnostic value was conducted using ROC curves. Circ-ANAPC7 expression levels were 5.623 ± 4.483, 28.396 ± 12.938, 91.867 ± 37.010, 202.525 ± 54.911, 337.633 ± 86.013, and 502.269 ± 98.410 from the control group to the very high group, respectively (

Indexed as

BiomarkerCirc-ANAPC7Myelodysplastic syndromeRisk stratification

Identifiers

PMID37304473
PMCPMC10247924
OpenAlexW4309489070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.